Cara Smith

1 week ago | yahoo.com | Cara Smith

To the millions of Americans who have recently retired, or who hope to retire soon, President Trump’s trade war and the ensuing global market panic has wrought a tremendous amount of anxiety over the future of their life’s savings. Since Trump announced his sweeping global tariffs on April 2, U.S. stock markets have nosedived, with the S&P down 4.2% and the Dow Jones down 3.2%. More than 60% of America’s top CEOs think we’re headed into a recession in the next six months.

1 week ago | insidehealthpolicy.com | Cara Smith

FDA in late March sent a warning letter to TheSafePills, an online pharmaceutical company that markets prescription medication directly to consumers, alleging the website offered unlawful sale of unapproved and misbranded drugs to U.S. patients, including opioid products. An Inside Health Policy review of the website on Friday (April 11) found consumers could also order antibiotics, injection fertility hormones and testosterone on TheSafePills without a prescription.

2 weeks ago | insidehealthpolicy.com | Charlie Mitchell |Cara Smith

The Trump White House has posted anxiously awaited guidance updating policies on artificial intelligence usage and acquisition by HHS and other federal agencies, promoting widespread government adoption of AI -- with “strong safeguards” -- and spelling out revised rules for procurement of AI products and services. But as the Trump administration touts its support for AI, it has slashed key health AI experts in FDA offices that help manufacturers gain approval and bring new devices to patients.

2 weeks ago | insidehealthpolicy.com | Cara Smith

ATA Action on Wednesday (April 9) launched a Virtual Foodcare Coalition that will advocate for use of virtual food and nutrition counseling to help manage chronic health conditions and prevent diseases -- a move by the telehealth group that aligns with HHS Secretary Robert F. Kennedy Jr.’s focus on “food as medicine” approach to tackling chronic diseases.

2 weeks ago | insidehealthpolicy.com | Cara Smith

Just as the Trump administration touts its support for digital health’s role in health care, the Department of Government Efficiency (DOGE) has slashed health technology experts in key FDA offices that help manufacturers gain approval and bring new devices to patients. A health technology expert told Inside Health Policy the mass FDA layoffs have disproportionally impacted artificial intelligence experts, calling into question how emerging AI technologies will gain FDA approval.